ARCHIVES

FDA Proposal On Dissemination of Off-Label Drug Information Doesn’t Go Far Enough, Cancer Groups Say

This article is from The Cancer Letter archive.

Vol. 22 No. 04 | January 26, 1996

Download PDF Visit The Full Archive

Related Articles

Letter to the Editor: NCI Should Continue Supporting Research In Special Populations

July 31, 1998

CCIRC Report Suggests Ways To Enhance Role Of Surgeons

July 22, 1977

Avastin doubles progression-free survival in metastatic disease.

May 27, 2005

Marie Lombardi NCAB Member, Dies; HHS Holding Up Board Appointments

April 23, 1982

NCAB Criticizes Coverage’ Of NCI Screening Statement

March 4, 1994

In Brief: Bishop Named Interim Chairman of NCAB; AACI Elects Wicha president, Herberman VP

December 12, 1997